Mark E. Lobatto
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Immunology top 10%
- Atherosclerosis and Cardiovascular Diseases
Papers in
- Biomaterials 10
- Nanoparticle-Based Drug Delivery 10
-
- Atherosclerosis and Cardiovascular Diseases 7
- Co-authors
- Willem J. M. Mulder (21 shared papers)Zahi A. Fayad (18 shared papers)Valentı́n Fuster (5 shared papers)Claudia Calcagno (13 shared papers)Edward A. Fisher (4 shared papers)Ronald E. Gordon (3 shared papers)Erik S.G. Stroes (8 shared papers)David P. Cormode (3 shared papers)
- Journals
- Journal of the American College of Cardiology (3 papers)Nanomedicine Nanotechnology Biology and Medicine (2 papers)Bioconjugate Chemistry (2 papers)Nature Reviews Drug Discovery (2 papers)Circulation (1 paper)
- Partner nations
- NetherlandsUnited StatesFrance
In The Last Decade
Mark E. Lobatto
23 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 97
- Biomaterials 567
- Immunology 367
- Cancer Research 187
- Immunology and Allergy 72
- Biomedical Engineering 537
Countries citing papers authored by Mark E. Lobatto
This map shows the geographic impact of Mark E. Lobatto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Lobatto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Lobatto more than expected).
Fields of papers citing papers by Mark E. Lobatto
This network shows the impact of papers produced by Mark E. Lobatto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Lobatto. The network helps show where Mark E. Lobatto may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Lobatto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 353 | |
| 2 | 2008 | 284 | |
| 3 | 2014 | 163 | |
| 4 | 2010 | 141 | |
| 5 | 2015 | 139 | |
| 6 | 2015 | 137 | |
| 7 | 2015 | 106 | |
| 8 | 2014 | 81 | |
| 9 | 2011 | 78 | |
| 10 | 2011 | 45 | |
| 11 | 2008 | 43 | |
| 12 | 2015 | 41 | |
| 13 | 2018 | 38 | |
| 14 | 2015 | 33 | |
| 15 | 2019 | 28 | |
| 16 | 2012 | 24 | |
| 17 | 2011 | 7 | |
| 18 | 2015 | 4 | |
| 19 | 2011 | 2 | |
| 20 | 2018 | 2 |
About Mark E. Lobatto
Mark E. Lobatto is a scholar working on Biomaterials, Immunology, Cancer Research, Cardiology and Cardiovascular Medicine and Biomedical Engineering, having authored 24 papers that have together received 1.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (10 papers), Atherosclerosis and Cardiovascular Diseases (7 papers), Protease and Inhibitor Mechanisms (4 papers), Cardiovascular Disease and Adiposity (4 papers), Cerebrovascular and Carotid Artery Diseases (3 papers), Cardiac Imaging and Diagnostics (2 papers), Photoacoustic and Ultrasonic Imaging (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Biomaterials (567 citations), Immunology (367 citations), Cancer Research (187 citations), Immunology and Allergy (72 citations) and Biomedical Engineering (537 citations). Mark E. Lobatto has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Willem J. M. Mulder, Zahi A. Fayad, Valentı́n Fuster, Claudia Calcagno, Edward A. Fisher, Ronald E. Gordon, Erik S.G. Stroes, David P. Cormode, François Fay and Gert Storm. Their work appears in journals such as Journal of the American College of Cardiology, Nanomedicine Nanotechnology Biology and Medicine, Bioconjugate Chemistry, Nature Reviews Drug Discovery and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.